Compare AFLAC Incorporated (AFL) vs FMC Corp (FMC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AFLAC Incorporated vs FMC Corp — how do they compare? AFLAC Incorporated trades at $121.25 (market cap $61.84B), while FMC Corp trades at $10.99 (market cap $1.45B). The key difference: AFLAC Incorporated is far larger — about 42.6× FMC Corp's market cap, and FMC Corp pays the higher dividend (2.76%). Which is the better fit depends on your goals.
| AFL | FMC | |
|---|---|---|
Market Cap | $61.84B | $1.45B |
Sector | Financials | Basic Materials |
52-Week High | $121.49 | $43.90 |
52-Week Low | $98.09 | $10.80 |
Enterprise Value | $70.50B | $5.59B |
Dividend Yield | 2.01% | 2.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aflac (AFL) trades at $121.49, up 0.5% with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a 25.32% net income margin and 16.47% ROE, though recent Q1 2026 earnings missed expectations. Analyst consensus is mixed with 28% buy ratings and a $113.57 price target below current levels. Recent developments include strong dividend performance and upcoming Q2 2026 results announcement on August 6, 2026.
The outlook remains cautiously optimistic with solid profitability and dividend stability, but faces headwinds from recent earnings misses and premium valuation pressure. Key opportunities include continued growth in Japan and U.S. markets, while risks involve medical cost inflation and uneven revenue trends. The stock's current premium to analyst targets suggests limited near-term upside potential.
FMC Corporation trades at $11.59, up 2.11% today, but remains in a bearish technical trend. The company reported a net loss of -$2.24 billion in 2025 with negative margins, though recent strategic moves include a $400 million minority investment from Tessenderlo Group and asset sales to reduce debt. Analyst consensus is mixed with a $17.00 price target, suggesting potential upside from current levels.
The outlook hinges on successful debt reduction and operational turnaround. Investment opportunity exists if cost-cutting and partnerships restore profitability, but risks include persistent revenue declines, high leverage, and competitive pressures in the agricultural sciences sector. Execution on strategic initiatives is critical for recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AFLAC Incorporated
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →
